From: Epidemiologic analysis of antimicrobial resistance in hospital departments in China from 2022 to 2023
2022Q1
2022Q2
2022Q3
2022Q4
2023Q1
2023Q2
Ampicillin
85.7
89.6
30.4
88.2
83.5
82.4
Cotrimoxazole
69.8
70.8
73.9
69.7
61.5
52.9
Ciprofloxacin
54
60.4
65.2
48.7
50.5
46.1
Chloramphenicol
25
50
45.8
34.5
28.2
Cefazolin
75
57.1
66.7
62.1
37.5
53.8